Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	G1 Therapeutics	Collegium Pharmaceutical	Provention Bio	Kadmon	Vanda Pharmaceuticals
Symbol	NASDAQ:GTHX	NASDAQ:COLL	NASDAQ:PRVB	NASDAQ:KDMN	NASDAQ:VNDA
Price Information
Current Price	$22.10	$23.59	$12.72	$4.59	$18.65
52 Week Range	Buy	Hold	Buy	Buy	Hold
MarketRank™
Overall Score	1.5	1.4	1.4	2.0	1.4
Analysis Score	3.5	1.2	3.5	3.5	1.0
Community Score	2.4	2.5	2.6	4.0	2.7
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	1.7	0.0	0.8	1.7	1.7
Earnings & Valuation Score	0.0	3.1	0.0	0.6	1.9
Analyst Ratings
Consensus Recommendation	Buy	Hold	Buy	Buy	Hold
Consensus Price Target	$49.17	$25.00	$30.75	$14.00	$15.40
% Upside from Price Target	122.47% upside	5.98% upside	141.75% upside	205.01% upside	-17.43% downside
Trade Information
Market Cap	$840.82 million	$815.79 million	$718.53 million	$787.25 million	$1.02 billion
Beta	2.44	1.27	3.34	1.68	0.56
Average Volume	1,759,138	773,280	1,126,041	3,990,948	606,319
Sales & Book Value
Annual Revenue	N/A	$296.70 million	N/A	$5.09 million	$227.19 million
Price / Sales	N/A	2.75	N/A	154.66	4.51
Cashflow	N/A	N/A	N/A	N/A	$2.88 per share
Price / Cash	N/A	N/A	N/A	N/A	6.47
Book Value	$6.80 per share	$2.61 per share	$1.72 per share	$0.95 per share	$7.70 per share
Price / Book	N/A	9.04	N/A	4.83	2.42
Profitability
Net Income	$-122,450,000.00	$-22,720,000.00	$-43,280,000.00	$-61,370,000.00	$115.55 million
EPS	($3.27)	($0.68)	($1.06)	($0.74)	$2.11
Trailing P/E Ratio	N/A	48.14	N/A	N/A	51.81
Forward P/E Ratio	N/A	14.30	N/A	N/A	33.91
P/E Growth	N/A	0.73	N/A	N/A	N/A
Net Margins	N/A	5.71%	N/A	-768.36%	8.02%
Return on Equity (ROE)	-49.35%	12.64%	-67.66%	-85.07%	4.56%
Return on Assets (ROA)	-41.53%	3.15%	-62.27%	-46.46%	3.88%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.10%	1.27%	N/A	0.02%	N/A
Current Ratio	7.45%	1.08%	9.23%	5.76%	6.35%
Quick Ratio	7.45%	1.01%	9.23%	5.76%	6.33%
Ownership Information
Institutional Ownership Percentage	77.89%	N/A	39.42%	94.78%	97.64%
Insider Ownership Percentage	14.49%	8.08%	14.40%	2.95%	5.90%
Miscellaneous
Employees	104	255	19	115	284
Shares Outstanding	38.05 million	34.58 million	56.49 million	171.51 million	54.88 million
Next Earnings Date	5/5/2021 (Estimated)	5/6/2021 (Estimated)	5/6/2021 (Estimated)	3/4/2021 (Estimated)	5/5/2021 (Estimated)
Optionable	Optionable	Optionable	Not Optionable	Optionable	Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources